Status:
UNKNOWN
Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases
Lead Sponsor:
The Netherlands Cancer Institute
Collaborating Sponsors:
Erasmus Medical Center
Maastricht University Medical Center
Conditions:
Breast Cancer
Breast Implant; Complications
Eligibility:
FEMALE
18-80 years
Brief Summary
Background: Implant-based breast reconstructions contribute considerably to the quality of life of breast cancer patients. A knowledge gap exists concerning the potential role of breast implants in th...
Detailed Description
There are various indications for implantation of a silicone breast implant. Most frequently, silicone breast implants are used in breast augmentation procedures for cosmetic reasons. In the field of ...
Eligibility Criteria
Inclusion
- surgery for first invasive breast cancer or ductal carcinoma in situ (DCIS) in the years 2000 to 2015 in the collaborating centres
Exclusion
- above the age of 60 at breast cancer diagnosis
- above the age of 80 years at time of inclusion
- Not residing in Netherlands
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT05400954
Start Date
July 1 2022
End Date
June 1 2025
Last Update
April 28 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland Medical Center
Heerlen, Limburg, Netherlands
2
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
3
Netherlands Cancer Institute Antoni van Leeuwenhoek
Amsterdam, North Holland, Netherlands
4
Velthuis Kliniek
Hilversum, North Holland, Netherlands